Bizily Scott: insider trades.
Bizily Scott reported 11 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($162K), across 1 company.
- Transactions
- 11
- Purchases (P)
- 0
- Sales (S)
- 5
- Companies
- 1
- Name as filed
- Bizily Scott
Companies
| Company | Relationship | Transactions |
|---|---|---|
| 4D Molecular Therapeutics, Inc. (FDMT) | Officer · Chief Legal Officer | 11 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-16 | 4D Molecular Therapeutics, Inc. | M | 1,635 | $4.14 | 10,252 | Form 4 |
| 2026-09-16 | 4D Molecular Therapeutics, Inc. | S | 1,635 | $13.65 | 8,617 | Form 4 |
| 2026-09-01 | 4D Molecular Therapeutics, Inc. | S | 584 | $14 | 8,617 | Form 4 |
| 2026-09-01 | 4D Molecular Therapeutics, Inc. | M | 584 | $6.49 | 9,201 | Form 4 |
| 2026-08-17 | 4D Molecular Therapeutics, Inc. | S | 1,635 | $12.2 | 8,617 | Form 4 |
| 2026-08-17 | 4D Molecular Therapeutics, Inc. | M | 1,635 | $4.14 | 10,252 | Form 4 |
| 2026-08-13 | 4D Molecular Therapeutics, Inc. | M | 1,635 | $4.14 | 10,252 | Form 4 |
| 2026-08-13 | 4D Molecular Therapeutics, Inc. | S | 1,635 | $12 | 8,617 | Form 4 |
| 2026-06-30 | 4D Molecular Therapeutics, Inc. | M | 5,752 | $6.49 | 15,183 | Form 4 |
| 2026-06-30 | 4D Molecular Therapeutics, Inc. | M | 814 | $4.14 | 9,431 | Form 4 |
| 2026-06-30 | 4D Molecular Therapeutics, Inc. | S | 6,566 | $14 | 8,617 | Form 4 |
Questions
What stock did Bizily Scott buy or sell?
Bizily Scott reported 11 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($162K), across 1 company.
Is Bizily Scott the same person as other filers with this name?
This page covers SEC CIK 1920738 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/bizily-scott-1920738.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.